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Background: Organic anion transporting polypeptide (Oatp) transporters at the blood–brain barrier (BBB) and the
blood-retinal barrier (BRB), which consists of retinal capillary endothelial cells and retinal pigment epithelial cells, are
major determinants of the control of anionic drugs into the brain and retina. Although Oatp1a4 (Slco1a4) and
Oatp1c1 (Slco1c1) are known to be expressed in the abluminal and luminal membrane of the rat BBB and Oatp1a4
is known to be expressed at the BRB, the expression and localization of Oatp1c1 at the BRB and subcellular
localization of Oatp1a4 at the BRB have received little attention. Therefore, the purpose of present study was to
determine the cellular and subcellular localization of Oatp1a4 and 1c1 at the BRB.
Methods: We used guinea pig polyclonal antibodies to Oatp1a4 and 1c1 for immunoblot and
immunohistochemical analysis to determine their cellular and subcellular distributions in the rat retina. We
compared these distributions with those of the glucose transporter 1 (GLUT1/Slc2a1). Whole brain, brain capillary
fractions and kidney were used as control.
Results: Oatp1a4 and 1c1 immunoreactivities were detected in the rat retinal capillaries and co-localized with
GLUT1, suggesting that both proteins are located on the abluminal and luminal membrane of the retinal capillary
endothelial cells. Oatp1a4 and 1c1 immunoreactivities were preferentially detected on the apical and basolateral
membrane of rat retinal pigment epithelial cells, respectively, suggesting that Oatp1a4 and 1c1 are localized on the
apical membrane and the basolateral membrane of the retinal pigment epithelial cells, respectively.
Conclusion: Oatp1a4 and 1c1 are present at the BRB and contribute to the transcellular transport of amphipathic
organic anions across the BRB.
Keywords: Inner blood-retinal barrier, Outer blood-retinal barrier, Blood–brain barrier, Organic anion transporting
polypeptide, Oatp1a4, Oatp1c1Background
In the retina, the blood-retinal barrier (BRB), which is
formed by complex tight junctions of retinal capillary endo-
thelial cells (inner BRB) and retinal pigment epithelial cells
(RPE; outer BRB), control the anatomical, biochemical, and
transport mechanisms that regulate the access of molecules
in the circulating blood to the neural retina [1,2]. Similarly,
the brain has two barriers: the blood–brain barrier (BBB)
and the blood-cerebrospinal fluid barrier (BCSFB) which* Correspondence: hosoyak@pha.u-toyama.ac.jp
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reproduction in any medium, provided the orconsist of brain capillary endothelial cells and choroid
plexus epithelial cells, respectively [3]. The tight junctions
between cells of the BRB and RPE at these boundaries cre-
ate physical barriers to diffusion of substances from the cir-
culating blood to the retina. However, the BRB is not an
impermeable barrier since essential nutrients are efficiently
transferred to the retina from the circulating blood, and en-
dobiotics and xenobiotics are selectively removed from the
retina across the BRB [1,4]. The inner and outer BRB ex-
press a variety of unique transporters which play a pivotal
role in the influx transport of essential molecules and the
efflux transport of hormones, neurotransmitter metabolites,
and drugs.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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elimination of amphipathic organic anions, such as estra-
diol 17-β glucuronide (E17βG) and dehydroepiandroster-
one sulfate (DHEAS), from the vitreous humor/retina
involves saturable mechanisms [1,5], suggesting that or-
ganic anion transporting polypeptides (Oatps) are involved
in the uptake of E17βG and DHEAS at the BRB. Mamma-
lian Oatps exhibit wide tissue expression with emphasis
on their expression in barrier cells [6]. Our previous study
revealed that Oatp1a4 (Oatp2/Slco1a4) and Oatp1c1
(Oatp14/Slco1c1) mRNAs are highly expressed in rat ret-
inal capillary endothelial cells compared with other retinal
cells [7]. Oatp1a4 and 1c1 exhibit broad substrate specifi-
city for amphipathic compounds and Oatp1a4 has a high
affinity for the cardiac glycoside, digoxin [8]. Immunohis-
tochemical staining of rat brain has shown that Oatp1a4
and 1c1 are localized in both the abluminal and luminal
membrane of the BBB [9,10]. These results and kinetic
analyses suggest that Oatp1a4 and 1c1 mediate uptake
from both brain and blood. At the BCSFB, Oatp1a4 and
1c1 have been reported to be localized at the basolateral
membrane of choroid plexus epithelial cells [9,10]. In the
retina, although Oatp1a4 is known to be localized at the
apical membrane of the RPE and is expressed in the ret-
inal capillary endothelial cells [7,11,12], there is little infor-
mation available about the expression and localization of
Oatp1c1 at the BRB and the subcellular localization of
Oatp1a4 at the inner BRB.
The purpose of this study was to determine the cellular
and subcellular localization of Oatp1a4 and 1c1 at the
BRB. We have produced specific antibodies to Oatp1a4
and 1c1, investigated the expression of Oatp1a4 and 1c1,




Male Wistar rats (100–200 g) and female Hartley guinea
pigs (300–400 g) were purchased from Japan SLC
(Hamamatsu, Japan). The investigations using animals
described in this report conformed to the provisions of
the Animal Care Committee, University of Toyama and
the Association for Research in Vision and Ophthalmol-
ogy Statement on the Use of Animals in Ophthalmic and
Vision Research.
Antibody preparation
Polyclonal antibodies to Oatp1a4 and 1c1 were raised
against amino acid residues 625–661 of rat Oatp1a4
(GenBank accession number: NP_571981) and 1–35 of rat
Oatp1c1 (GenBank accession number: NP_445893.1). The
specificity of these amino acid sequences was confirmed
by NCBI protein-protein BLAST search against the
dataset of all non-redundant protein sequences. Thesepolypeptides were expressed as glutathione S-transferase
(GST) fusion proteins using the pGEX4T-2 plasmid vector
(GE Healthcare, Chalfont St. Giles, UK). The fusion pro-
tein was purified with glutathione-Sepharose 4B (GE
Healthcare), emulsified with Freund’s complete adjuvant
(Difco, Detroit, MI, USA), and injected subcutaneously
into female Hartley guinea pigs at intervals of 2 weeks.
Two weeks after the sixth injection, affinity-purified anti-
bodies were prepared, first using protein G-Sepharose (GE
Healthcare) and then using antigen peptides coupled to cy-
anogens bromide-activated Sepharose 4B (GE Healthcare).
For the preparation of affinity media, polypeptides free of
GST were obtained by elution of the cleaved polypeptide
after in-column thrombin digestion of fusion proteins
bound to glutathione-Sepharose 4B. Guinea pig polyclonal
anti-Oatp1a4 antibody was prepared in previous study [13].
Immunoblot analysis
Under pentobarbital anesthesia (50 mg/kg bodyweight, i.p.),
rats were transcardially perfused with phosphate-buffered
saline (PBS). Rat brain capillary fraction was prepared as
described previously with minor modification [14]. In brief,
cerebrum was excised, cut into 2 mm pieces, and homoge-
nized in PBS using a Potter-Elvehjem homogenizer. The
homogenate was added to the same volume of 32% dextran
solution, and the mixture was centrifuged (4,500 g, 10 min,
4°C). The resulting pellets were washed with PBS and
suspended in Tris/sucrose buffer (250 mM sucrose, 10 mM
Tris–HCl, and 1 mM EGTA, pH 7.4).
The retina, brain, brain capillary fraction, and kidney
were homogenized using the nitrogen cavitation technique
(800 psi, 30 min, 4°C) in Tris/sucrose buffer containing
protease inhibitor cocktail (Sigma, St. Louis, MO, USA),
and homogenized samples were centrifuged at 10,000 g
for 15 min. The supernatants were then centrifuged at
100,000 g for 1 h, and a crude membrane fraction was
obtained from the pellets. The protein concentration in
each sample was determined using a DC protein assay kit
(Bio-Rad, Hercules, CA, USA). Crude membrane protein
(5 μg/lane or 20 μg/lane) was separated on a sodium
dodecyl sulfate (SDS)-polyacrylamide gel and subsequently
electrotransferred to a polyvinylidene difluoride mem-
brane. Following incubation with Tris-buffered saline
(TBS; 25 mM Tris–HCl and 125 mM NaCl, pH 7.4)
containing 0.1% Tween 20 and 5% skimmed milk for 12–
16 h at 4°C, the membranes were incubated with guinea
pig polyclonal anti-Oatp1a4 antibody (0.1 μg/mL; [13]) or
guinea pig polyclonal anti-Oatp1c1 antibody (0.1 μg/mL)
for 3 h at 15–25°C. Antigen absorption was performed by
incubating guinea pig anti-Oatp1a4 antibody or anti-
Oatp1c1 antibody with respective GST-fused antigen
(10 μg/mL) for 1 h at 4°C. The membranes were subse-
quently incubated with horseradish peroxidase-conjugated
anti-guinea pig antibody. The bands were then visualized
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Western Blotting Detection System; GE healthcare).
Immunohistochemical analysis
Under pentobarbital anesthesia (100 mg/kg body weight, i.
p.), rats were perfused transcardially with 4% formaldehyde
in 0.1 M phosphate buffer (pH 7.4). Then their eyeballs or
brains were isolated and immersed in 30% sucrose/phos-
phate buffer. Frozen sections (15 μm in thickness) were cut
from the frozen eye or brain using a cryostat (CM1900;
Leica, Heidelberg, Germany), mounted on silanized glass
slides (DAKO, Carpinteria, CA, USA), and air-dried. Fol-
lowing incubation with 10% goat serum (Nichirei, Tokyo,
Japan) for 1 h at room temperature, sections were incu-
bated with guinea pig polyclonal anti-Oatp1a4 antibody
(1 μg/mL [13]) or guinea pig polyclonal anti-Oatp1c1 anti-
body (2 μg/mL) and rabbit polyclonal anti-GLUT1 antibody
(0.5 μg/mL [15]) for 12 h at 4°C. Sections were subse-
quently incubated with Alexa Fluor 488-conjugated (1:200;
Life Technologies, Carlsbad, CA) and Cy3-conjugated sec-
ondary antibodies (1:200; Merck Millipore, Billerica, MA)
for 2 h at room temperature. Nuclei were stained by incu-
bating with 4 μM 4',6-diamidino-2-phenylindole in PBS(−)
for 5 min at room temperature.
Images were captured using a confocal laser microscope
(TCS-SP5; Leica) equipped with a blue diode/argon/green
diode laser system. To avoid bleed-through into adjacent
detection channels, 4',6-diamidino-2-phenylindole, Alexa
Fluor 488, and Cy3 were excited sequentially using the
405, 488, and 561 nm excitation laser wavelengths, re-
spectively. Emissions were collected using the spectral de-
tection system, configured with a galvanometer diffraction
grating in combination with a variable slit for high-
resolution wavelength separation. Images were acquired
using an appropriate pinhole to obtain 1 Airy unit. All im-
ages were captured using a confocal software (LAS AF,
Leica), digitized at 8-bit resolution into an array of 1024 ×
1024 pixels.
Data analysis
Using the confocal software (LAS AF), the line scanning
of images was carried out, and the co-localization stud-
ies were performed by the overlap coefficient, proposed
by Manders et al. [16].
Results
Localization of Oatp1a4 in the rat retina
A broad band at about 92 kDa was detected with anti-
Oatp1a4 antibody in the crude membrane fraction from
adult rat brain capillary fraction, whereas no band between
75 and 100 kDa was detected in rat brain (Figure 1a1). In
addition, a single band at about 92 kDa was detected with
anti-Oatp1a4 antibody in the crude membrane fractions
from adult rat retina (Figure 1a2). These bands wereabsent after pre-absorbing anti-Oatp1a4 antibody with
the antigen peptide (Figure 1a1 and 1a2). High Oatp1a4
immunoreactivities were detected in the brain capillar-
ies (Figure 1b). Double immunostaining with GLUT1
(red, Figure 1c2), which is known to be expressed in
both the abluminal and luminal membrane of brain ca-
pillaries, showed that Oatp1a4 (green, Figure 1c1) over-
lapped on the abluminal and luminal membrane of the
capillaries (yellow, Figure 1c3). These features indicate that
Oatp1a4 is expressed in both the abluminal and luminal
membrane of rat brain capillaries. The localization of
Oatp1a4 at the BBB is identical to that described in a pre-
vious report [9].
In the retina, immunostaining of Oatp1a4 (green,
Figure 1d1) was observed along the retinal capillaries in the
inner plexiform layer, inner nuclear layer, outer plexiform
layer (arrow head) and in the RPE (arrow). The immunore-
activities derived from Oatp1a4 were detected around the
nucleus in the retinal capillary endothelial cells (Figure 1d2)
and above the nucleus in the RPE (Figure 1d3). Moreover,
double immunostaining with GLUT1 (red, Figure 1e3),
which is known to be expressed in both the abluminal and
luminal membrane of retinal capillaries [17], showed that
Oatp1a4 (green, Figure 1e2) overlapped on the abluminal
(arrow head) and luminal membrane of retinal capillar-
ies (double arrow head, yellow, Figure 1e1; overlap coef-
ficient = 0.812). These features indicate that Oatp1a4 is
expressed in both the abluminal and luminal membrane
of rat retinal capillaries. To assess the distribution of
Oatp1a4 in the retinal capillaries, line scanning was
performed to measure the fluorescence intensity immu-
nostained for Oatp1a4 (green, Figure 1e4) and GLUT1
(red, Figure 1e4). The relative fluorescence intensity for
Oatp1a4 was strongly observed at the abluminal mem-
brane of the retinal capillaries compared with the luminal
membrane, indicating that Oatp1a4 is preferentially local-
ized on the abluminal membrane of the retinal capillaries.
In rat RPE, Oatp1a4 immunoreactivities were observed
above the nucleus of the RPE (arrow, green, Figure 1d3
and 1f2), and GLUT1, which is known to be expressed in
both the apical and basolateral membranes of RPE [17]
(red, Figure 1f3), and Oatp1a4 overlapped on the apical
membrane of RPE (arrow, yellow, Figure 1f1 and 1f4) but
was below the detection threshold on the basolateral
membrane (Figure 1f4). The overlap coefficient of the im-
munoreactivities for Oatp1a4 and GLUT1 in Figure 1f1
was obtained to be 0.846. Consequently, these results indi-
cate that Oatp1a4 is dominantly expressed in the apical
membrane of rat RPE.
Localization of Oatp1c1 in the rat retina
Using immunoblotting with the crude membrane frac-
tion from rat brain capillary fraction and brain, anti-
Oatp1c1 antibody was recognized as a single band at
Figure 1 Expression and localization of Oatp1a4 in rat brain/retinal capillary endothelial cells and RPE. (a) Immunoblotting with Oatp1a4
antibodies using proteins (5 μg/lane) prepared from rat brain capillary fraction, brain (a1), and retina (a2) in the absence [antigen(-)] or presence
[antigen(+)] of Oatp1a4 antigens. Arrow heads indicates the expected position of the band. (b) Oatp1a4 immunofluorescence in the rat cerebral
cortex (Cx). (c) Oatp1a4 (green, c1 and c3) overlapped with GLUT1 (red, c2 and c3) in brain capillaries. (d) Oatp1a4 (green) in the retinal capillaries
(arrow heads and double arrow heads) and the RPE (arrows) of rat retina. Oatp1a4 was observed around the nucleus (blue) of retinal capillaries
(arrow head and double arrow head, d2) and above the nucleus of the RPE (arrows, d3). (e) Oatp1a4 (green, e1 and e2) overlapped with GLUT1
(red, e1 and e3) on the abluminal (arrow head) and luminal membrane (double arrow head) of retinal capillaries. The blue line between A and B
indicates the scanned line (e1), and the relative fluorescence intensity is plotted in green for Oatp1a4 and red for GLUT1 (e4), which is expressed
in the abluminal (AL) and luminal (L) membrane of the retinal capillaries. (f) Oatp1a4 (green, f1 and f2) overlapped with GLUT1 (red, f1 and f3) on
the apical membrane (arrows) of rat RPE. The blue line between A and B indicates the scanned line (f1), and the relative fluorescence intensity is
plotted in green for Oatp1a4 and red for GLUT1 (f4), which is expressed in the apical (Ap) and basolateral (Ba) membrane of the RPE. GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; POS, photoreceptor
outer segments; CH, choroid. Scale bar: 50 μm (b, d1), 5 μm (c, d2, e), 10 μm (d3, f).
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of band detected was consistent with previous results [18],
indicating the high specificity of the antibody for rat
Oatp1c1. A single band at about 73 kDa with anti-Oatp1c1
antibody was also detected in the retina (Figure 2a3). These
bands were absent after pre-absorbing anti-Oatp1c1 anti-
body with the antigen peptide (Figure 2a1 and 2a3).
Oatp1c1 immunoreactivities were detected in brain capil-
laries (Figure 2b). Double immunostaining with GLUT1
(red, Figure 2c2), which is known to be expressed in both
the abluminal and luminal membrane of brain capillaries,
showed that Oatp1c1 (green, Figure 2c1) overlapped on the
abluminal and luminal membrane of capillaries (yellow,
Figure 2c3). These features indicate that Oatp1c1 isexpressed in both the abluminal and luminal membrane of
rat brain capillaries and the localization of Oatp1c1 at the
BBB is identical to that described in a previous report [10].
In the retina, immunostaining of Oatp1c1 (green,
Figure 2d1) was observed along the retinal capillaries in
the inner plexiform layer, inner nuclear layer, inner and
outer plexiform layer (arrow head), and in the RPE (arrow
and triple arrow head). The immunoreactivities derived
from Oatp1c1 were detected around the nucleus in the
retinal capillary endothelial cells (Figure 2d2) and the RPE
(Figure 2d3). Double immunostaining with GLUT1 (red,
Figure 2e3), which is known to be expressed in both the
abluminal and luminal membrane of retinal capillaries
[17], showed that Oatp1c1 (green, Figure 2e2) overlapped
Figure 2 Expression and localization of Oatp1c1 in rat brain/retinal capillary endothelial cells and RPE. (a) Immunoblotting with Oatp1c1
antibodies using proteins (20 μg/lane) prepared from rat brain capillary fraction (a1), brain (a1 and a2), retina (a3), and kidney (a2, negative
control) in the absence [antigen(-)] or presence [antigen(+)] of Oatp1c1 antigens. Arrow heads indicate the expected position of the band. (b)
Oatp1c1 immunofluorescence in the rat cerebral cortex (Cx). (c) Oatp1c1 (green, c1 and c3) overlapped with GLUT1 (red, c2 and c3) in brain
capillaries. (d) Oatp1c1 (green) in the retinal capillaries (arrow heads and double arrow heads) and the RPE (arrows and triple arrow heads) of rat
retina. Oatp1c1 was observed around the nucleus (blue) of retinal capillaries (arrow head and double arrow head, d2) and around the nucleus of
the RPE (arrows and triple arrow heads, d3). (e) Oatp1c1 (green, e1 and e2) overlapped with GLUT1 (red, e1 and e3) on the abluminal (an arrow
head) and luminal membrane (a double arrow head) of retinal capillaries. The blue line between A and B indicates the scanned line (e1), and the
relative fluorescence intensity is plotted in green for Oatp1c1 and red for GLUT1 (e4), which is expressed in the abluminal (AL) and luminal (L)
membrane of the retinal capillaries. (f) Oatp1c1 (green, f1 and f2) overlapped with GLUT1 (red, f1 and f3) on the apical (arrows) and basolateral
membrane (triple arrow heads) of rat RPE. The blue line between A and B indicates the scanned line (f1), and the relative fluorescence intensity is
plotted in green for Oatp1c1 and red for GLUT1 (f4), which is expressed in the apical (Ap) and basolateral (Ba) membrane of the RPE. Scale bar:
50 μm (b, d1), 5 μm (c, d2, e), 10 μm (d3, f).
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of retinal capillaries (double arrow head, yellow,
Figure 2e1, overlap coefficient = 0.789). To evaluate the
intracellular distribution of Oatp1c1 in the retinal capil-
lary endothelial cells, line scanning was performed to
measure the fluorescence intensity immunostained for
Oatp1c1 (green, Figure 2e4) and GLUT1 (red, Figure 2e4).
The relative fluorescence intensity for Oatp1c1 showed
peaks not only inside the cytoplasm but also at the lu-
minal and abluminal membrane of the retinal capillary
endothelial cells. Thus, it is indicated that Oatp1c1 is
expressed in both the abluminal and luminal membrane
of the retinal capillaries. Oatp1c1 immunoreactivity(green, Figure 2d3 and 2f1) was observed along both
the retinal (arrow) and choroid sides (triple arrow head)
of the RPE and GLUT1, which is known to be
expressed in both the apical and basolateral membrane
of the RPE [17] (red, Figure 2f3), showed that Oatp1c1
mainly overlapped on the basolateral membrane of the
RPE (triple arrow head, yellow, Figure 2f1; overlap coef-
ficient = 0.795). The relative fluorescence intensity for
Oatp1c1 at the basolateral membrane of the RPE is
greater than that at the apical membrane of the RPE
(Figure 2f4). These results indicate that Oatp1c1 is pre-
ferentially expressed in the basolateral membrane of rat
RPE.
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The present study demonstrates that retinal capillary
endothelial cells and retinal pigment epithelial cells ex-
press proteins for Oatp1a4 and 1c1 (Figures 1 and 2).
The presence of these transporters at the inner and
outer BRB leads us to propose that Oatp1a4 and 1c1 are
able to transport amphipathic organic anions in the
retina.
We further demonstrated the immunoreactivities of
Oatp1a4 and 1c1 on the inner and outer sides of the endo-
thelium nuclei along with GLUT1 which is a marker for
both the abluminal and luminal membrane of retinal ca-
pillaries [17] and showed that Oatp1a4 and 1c1 are located
on both the abluminal and luminal membrane of retinal
capillary endothelial cells (Figures 1e1 and 2e1). These
expressional patterns are similar to the finding that
Oatp1a4 and 1c1 are localized on both the abluminal
and luminal membrane of brain capillary endothelial
cells (Figures 1c3 and 2c3) [9,10]. Oatp1a4 and 1c1 are
preferentially located on the apical and basolateral mem-
brane, respectively, of rat RPE. The localization of Oatp1a4
at the RPE is consisted with a previous report [12].
Oatp1a4 and 1c1 mediate the cellular uptake of amphi-
pathic organic anions from the brain side and the blood
side of the BBB [10,19]. In the retina, when [3H]E17βG
was injected into the vitreous humor, its subsequent eli-
mination from the vitreous humor/retina across the BRB
was carrier-mediated, and the elimination was completely
inhibited by the presence of probenecid, while digoxin had
a much weaker effect [5]. Our immunohistochemical stu-
dies indicate that Oatp1a4 is preferentially expressed at
the retinal side of the inner and outer BRB (Figure 1e
and 1f). Although Oatp1a4 on the retinal side of the inner
and outer BRB is involved in the uptake of E17βG from the
retina, the partial inhibition by digoxin suggested that an
additional uptake transporter, such as Oatp1c1, on the re-
tinal side of the inner BRB is involved in the uptake of
E17βG from the retina. When L-[125I]-thyroxin, ([125I]T4)
was injected into the carotid artery, the subsequent uptake
of [125I]T4 into the brain was inhibited in the presence of
50 μM T4, but not into the retina [20], suggesting that
Oatp1c1 on the luminal side of the BBB, but not the
BRB, is involved in the uptake of T4 from the circulating
blood. The sensitivity of Oatp1c1 on the luminal and
basolateral membrane of the inner and outer BRB is less
than that of the BBB. Further studies are needed to deter-
mine concentration-dependent inhibition of the uptake of
[125I]T4 by the retina or brain.Conclusion
Oatp1a4 and 1c1 are respectively localized on both the
abluminal and luminal membrane of rat retinal capillary
endothelial cells, and on the apical and basolateralmembrane of the RPE. Our results support the hypothesis
that Oatp1a4 and 1c1 contribute to the transcellular trans-
port of amphipathic organic anions across the BRB in both
the blood-to-retina and retina-to-blood directions.
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